Old Web
English
Sign In
Acemap
>
authorDetail
>
Zhangma Huang
Zhangma Huang
Pharmacology
Pharmacokinetics
Hepatitis C Virus NS5A Inhibitor
Medicine
Tolerability
3
Papers
13
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A first-in-human trial of GLS4, a novel inhibitor of hepatitis B virus capsid assembly, following single- and multiple-ascending oral dose studies with or without ritonavir in healthy adult volunteers
2019
Antimicrobial Agents and Chemotherapy
Nan Zhao
Bo Jia
Hong Zhao
Junyu Xu
Xiaoyan Sheng
Lin Luo
Zhangma Huang
Xingan Wang
Qingyun Ren
Yingjun Zhang
Xia Zhao
Yimin Cui
Show All
Source
Cite
Save
Citations (12)
Safety, Tolerability and Pharmacokinetics of Yimitasvir Phosphate Capsule, a Novel Oral Hepatitis C Virus NS5A Inhibitor, in Healthy Chinese Volunteers
2019
Clinical Drug Investigation
Nan Zhao
Ran Xie
Xia Zhao
Hong Zhao
Bo Jia
Yingjun Zhang
Lin Luo
Zhangma Huang
Jing Li
Xingan Wang
Huan-yan
Bixia He
Hongming Xie
Qingyun Ren
Yimin Cui
Show All
Source
Cite
Save
Citations (1)
Safety, tolerability and pharmacokinetics of a novel oral hepatitis C virus NS5A inhibitor DAG181PA Capsules in Chinese healthy volunteers
2018
Ran Xie
Xia Zhao
Nan Zhao
Lin Luo
Zhangma Huang
Hongming Xie
Yingjun Zhang
Junyu Xu
Yimin Cui
Show All
Source
Cite
Save
Citations (0)
1